MSP joins Manchester-US trade mission



MSP joins Manchester-US trade mission

LEADING science and technology operator Manchester Science Partnerships has joined a high level trade mission to the US showcasing the unique opportunities Greater Manchester offers innovative bio-medical companies.

MSP’s Managing Director Thomas Renn and Head of Sales Matt Lee are part of the Health Innovation Manchester delegation attending The MedTech Conference in San Jose and also visiting leading health innovation economies in the Bay Area in California and the Greater Boston Area in Massachusetts.

The delegation, which includes a number of MSP customers and partners, including NorthWest EHealth, Oxford Road Corridor, the University of Manchester, Manchester Metropolitan University and is led by the city’s inward investment agency, MIDAS, will showcase the breadth and quality of potential partnership opportunities that exist following the city region’s £6bn pa health and social care devolution.

Their message is that Manchester offers life science businesses, including medtech and data companies, contract research organisations (CROs) and drug developers, an ideal location for testing and fast-track adoption of innovative treatments, services, and products.

The devolution deal with the government - the only one of its kinds in England - has enabled the city region to develop integrated decision making structures and a partnership of exceptional academic and clinical assets giving life science companies direct access to the largest integrated NHS cluster in the UK. One example is the world’s first large-scale, real time randomized clinical trial, the GSK-sponsored Salford Lung Study.

The delegation, will highlight Manchester’s strengths in medtech, digital health, precision medicine and Greater Manchester’s excellence in research and health informatics.

Thomas Renn, said: “We are excited to spend time in San Jose, San Francisco and Boston – the leading life science hubs in the US, which will provide us with the opportunities to connect with key decision makers, entrepreneurs, start-ups, and academia in other cities.

“Events like this are perfect to share knowledge, build contacts and explore how we revolutionise healthcare through the disruptive power of digital technology on both an international and global scale and to explore opportunities for partnerships.”

Click here to read Thomas Renn’s insights on trends in the medtech sector and MSP’s Chief Executive Rowena Burns on Manchester’s compelling investment offer for international medtech companies.